EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling the association between gut microbiota and chemotherapy efficacy: a two-sample Mendelian randomization study

Zixuan Jia iD, Xiufeng Liu, Wei Liao iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.03948-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Zixuan Jia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen Universit…. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Gastrointestinal Microbiome, Genome-Wide Association Study. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging evidence has underscored the complex link between gut microbiota and chemotherapy efficacy; however, establishing causality remains elusive due to confounding factors. This study, leveraging bidirectional two-sample Mendelian randomization (MR) analyses, explores the casual relationship between gut microbiota and chemotherapy efficacy. Utilizing genome-wide association study (GWAS) data from the MiBioGen consortium for gut microbiota and IEU Open GWAS for chemotherapy efficacy, we employed genetic variants as instrumental variables (IVs). The inverse variance weighted (IVW) method, weighted median estimator (WME), and MR-Egger regression method were applied, with sensitivity analyses ensuring robustness. Furthermore, we conducted reverse MR analyses between chemotherapy efficacy and identified significant gut microbial taxa. The results indicated that genus Butyricicoccus (OR = 3.7908, 95% CI: 1.4464–9.9350, P = 0.01), Dorea (OR = 3.3295, 95% CI: 1.2794–8.6643, P = 0.01), Hungatella (OR = 2.6284, 95% CI: 1.0548–6.5498, P = 0.04), and Turicibacter (OR = 2.5694, 95% CI: 1.0392–6.3526, P = 0.04) were positively associated with chemotherapy efficacy using the IVW method. Conversely, family Porphyromonadaceae (OR = 0.2283, 95% CI: 0.0699–0.7461, P = 0.01) and genus Eggerthella (OR = 0.4953, 95% CI: 0.2443–1.0043, P = 0.05) exhibited negative associations. WME demonstrated consistent results with IVW method only for genus Eggerthella (OR = 0.3343, 95% CI: 0.1298–0.8610, P = 0.02). No significant heterogeneity or horizontal pleiotropy was observed. Reverse MR analyses revealed no significant causal effect of chemotherapy on identified gut microbiota. This study sheds light on the intricate relationship between gut microbiota, with a particular emphasis on the genus Eggerthella , and chemotherapy efficacy, offering valuable insights for refining cancer treatment strategies. IMPORTANCE Global advancements in cancer treatment, particularly in chemotherapy, have notably decreased mortality rates in recent years. However, the correlation between gut microbiota and chemotherapy efficacy remains elusive. Our study, emphasizing the role of genus Eggerthella , represented a crucial advance in elucidating this intricate interplay. The identified associations offer potential therapeutic targets, contributing to global efforts for enhanced treatment precision and improved patient outcomes. Furthermore, our findings hold promise for personalized therapeutic interventions, shaping improved strategies in the ever-evolving landscape of cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mendelian Randomization AnalysisGastrointestinal MicrobiomeGenome-Wide Association StudyHumansAntineoplastic AgentsBacteriaNeoplasmsPolymorphism, Single NucleotideTreatment Outcome

Stichwörter der Autor:innen

Mendelian randomizationchemotherapy efficacygenus Eggerthellagut microbiota

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Intensive Care Unit, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Biotherapy Center/Melanoma and Sarcoma Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

ORCID-Profile: Zixuan Jia, Wei Liao

Zitieren

APA

Jia, Z., Liu, X., & Liao, W. (2024). Unraveling the association between gut microbiota and chemotherapy efficacy: a two-sample Mendelian randomization study. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03948-23

Vancouver

Jia Z, Liu X, Liao W. Unraveling the association between gut microbiota and chemotherapy efficacy: a two-sample Mendelian randomization study. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03948-23

BibTeX
@article{Jia2024,
  author = {Jia, Zixuan and Liu, Xiufeng and Liao, Wei},
  title = {Unraveling the association between gut microbiota and chemotherapy efficacy: a two-sample Mendelian randomization study},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.03948-23}
}
Kostenlos starten →